Cita APA (7a ed.)

F, L., F, W., C, Z., Q, W., T, Z., & YL, Z. (2020). miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]. Dove Medical Press.

Cita Chicago Style (17a ed.)

F, Li, Wang F, Zhu C, Wei Q, Zhang T, y Zhou YL. MiR-221 Suppression Through Nanoparticle-Based MiRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]. Dove Medical Press, 2020.

Cita MLA (8a ed.)

F, Li, et al. MiR-221 Suppression Through Nanoparticle-Based MiRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]. Dove Medical Press, 2020.